title: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible?
abstract: OBJECTIVE
  Our aim was to determine the value of echo-planar diffusion-weighted MR imaging (epiDWI) in differentiating various types of primary parotid gland tumors.
  
  
  METHODS
  One hundred forty-nine consecutive patients with suspected tumors of the parotid gland were examined with an epiDWI sequence by using a 1.5T unit. Image analysis was performed by 2 radiologists independently, and the intraclass correlation coefficient was computed. Histologic diagnosis was obtained in every patient. For comparison of apparent diffusion coefficients (ADCs), a paired 2-tailed Student t test with a Bonferroni correction was used.
  
  
  RESULTS
  In 136 patients, a primary parotid gland tumor was confirmed by histology. Among the observers, a high correlation was calculated (0.98). ADC values of pleomorphic adenomas were significantly higher than those of all other entities, except for myoepithelial adenomas (P = .054). ADC values of Warthin tumors were different from those of myoepithelial adenomas, lipomas, and salivary duct carcinomas (P < .001, 0.013, and .037, respectively). Mucoepidermoid carcinomas, acinic cell carcinomas, and basal cell adenocarcinomas were not differentiable from Warthin tumors (P = .094, .396, and .604, respectively).
  
  
  CONCLUSIONS
  epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on the basis of ADC values solely. Therefore, further studies combining DWI, morphologic criteria, and probably other MR imaging techniques seem warranted.
authors.affiliation: Department of Diagnostic and Interventional Radiology, Diagnostic Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. c.habermann@uke.uni-hamburg.de
authors.forename: C R
authors.initials: CR
authors.lastname: Habermann
authors.forename: C
authors.initials: C
authors.lastname: Arndt
authors.forename: J
authors.initials: J
authors.lastname: Graessner
authors.forename: L
authors.initials: L
authors.lastname: Diestel
authors.forename: K U
authors.initials: KU
authors.lastname: Petersen
authors.forename: F
authors.initials: F
authors.lastname: Reitmeier
authors.forename: J O
authors.initials: JO
authors.lastname: Ussmueller
authors.forename: G
authors.initials: G
authors.lastname: Adam
authors.forename: M
authors.initials: M
authors.lastname: Jaehne
mesh_terms: D000235:Adenolymphoma / Q000473:pathology; D008949:Adenoma, Pleomorphic / Q000473:pathology*; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002280:Basal Cell Carcinoma / Q000473:pathology; D018277:Carcinoma, Mucoepidermoid / Q000473:pathology; D003937:Diagnosis, Differential; D017352:Echo-Planar Imaging; D005260:Female; D006801:Humans; D008067:Lipoma / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009208:Myoepithelioma / Q000473:pathology*; D010306:Parotid Gland / Q000473:pathology*; D011446:Prospective Studies; D012468:Salivary Gland Neoplasms / Q000473:pathology; D055815:Young Adult